Downstream invasive testing, revascularization, and major adverse cardiovascular events following coronary CT angiography with and without fractional flow reserve derived from computed tomography: A propensity-matched real-world cohort study

Cardiovasc Revasc Med. 2026 Oct 8:S1553-8389(26)00401-X. doi: 10.1016/j.carrev.2026.10.004. Online ahead of print.ABSTRACTBACKGROUND: Fractional flow reserve derived from computed tomography (FFR-CT) enables combined anatomical and physiological assessment of coronary artery disease using coronary c

A Adarsh Vallurupalli

LDL-C management simplified: The National Lipid Association lipid simplified series

J Clin Lipidol. 2026 Oct 1:S1933-2874(26)00527-1. doi: 10.1016/j.jacl.2026.09.020. Online ahead of print.ABSTRACTAtherosclerotic heart disease is a leading cause of morbidity and mortality, with the magnitude of atherosclerotic cardiovascular disease (ASCVD) event reduction being proportional to the

E Eugenia Gianos

Prevalence and prognostic significance of intracranial lesions assessed with MRI in infective endocarditis patients: Data from the Vesuve study

Rev Neurol (Paris). 2026 Oct 26:S0035-3787(26)00611-9. doi: 10.1016/j.neurol.2026.09.009. Online ahead of print.ABSTRACTBACKGROUND: Infective endocarditis (IE) is a life-threatening disease. Magnetic resonance imaging (MRI) is efficient to detect cerebral IE related lesions, which are known to worse

P P Clottes

LDL-c and residual cardiovascular risk in patients with coronary artery disease

Ann Cardiol Angeiol (Paris). 2026 Oct 26:S0003-3928(26)00098-3. doi: 10.1016/j.ancard.2026.102093. Online ahead of print.ABSTRACTIn secondary prevention, current therapeutic management of dyslipidemia primarily aims to reduce low-density lipoprotein cholesterol (LDL-c) levels, as LDL-c is a major dr

T Thomas de Saint Nicolas

Re-Evaluating Fluid and Sodium Restriction in Heart Failure: An Evidence-Based, Patient-Centered Approach

Crit Care Nurs Clin North Am. 2026 Dec;38(4):609-619. doi: 10.1016/j.cnc.2026.07.010. Epub 2026 Aug 19.ABSTRACTFluid and sodium restrictions have traditionally been central to heart failure management, yet emerging evidence questions the benefit of rigid limits. The current research has revealed no

H Heather Przybyl

Small Annulus: Follow-Up Marker Rather Than Treatment Selector?

No abstractJACC Cardiovasc Interv. 2026 Oct 26;19(20):2817. doi: 10.1016/j.jcin.2026.08.022.NO ABSTRACTPMID:42933929 | DOI:10.1016/j.jcin.2026.08.022

W Wei Wang

ROBIN to the Rescue: Balloon Laceration for LVOT Obstruction After Incomplete LAMPOON in Valve-in-Ring TMVR

No abstractJACC Cardiovasc Interv. 2026 Oct 26;19(20):2800-2802. doi: 10.1016/j.jcin.2026.07.045.NO ABSTRACTPMID:42933924 | DOI:10.1016/j.jcin.2026.07.045

T Tyler Q Andrews

Cerebral Embolism in Transfemoral Carotid Artery Stenting Using Proximal Protection and MicroNet-Covered Stents: PROXGUARD Study

No abstractJACC Cardiovasc Interv. 2026 Oct 26;19(20):2797-2799. doi: 10.1016/j.jcin.2026.07.048.NO ABSTRACTPMID:42933923 | DOI:10.1016/j.jcin.2026.07.048

A Andrey Karpenko

Two-Year Outcomes of the Prospective THRILLER Registry on Popliteal and Infrapopliteal Endovascular Interventions for CLTI

JACC Cardiovasc Interv. 2026 Oct 26;19(20):2759-2771. doi: 10.1016/j.jcin.2026.07.044.ABSTRACTBACKGROUND: Over 70% of patients with chronic limb-threatening ischemia (CLTI) present with below-the-knee disease, and there is a growing trend towards endovascular revascularization.OBJECTIVES: The Dutch

D Dieder J Stolk

Impact of Recurrent Mitral Regurgitation Following Mitral Transcatheter Edge-to-Edge Repair on Long-Term Outcomes

JACC Cardiovasc Interv. 2026 Oct 26;19(20):2743-2755. doi: 10.1016/j.jcin.2026.07.015.ABSTRACTBACKGROUND: Residual mitral regurgitation (MR) after mitral transcatheter edge-to-edge repair (M-TEER) is a major determinant of outcome. However, the prognostic impact of recurrent mitral regurgitation (re

C Christoph Pauschinger

Periprocedural Pulmonary Hypertension and Outcomes After Mitral Valve Transcatheter Edge-to-Edge Repair

JACC Cardiovasc Interv. 2026 Oct 26;19(20):2726-2739. doi: 10.1016/j.jcin.2026.08.017.ABSTRACTBACKGROUND: Pulmonary hypertension (PH) is common in patients undergoing mitral valve transcatheter edge-to-edge repair (M-TEER), but the prognostic significance of periprocedural PH changes remains uncerta

J Junichi Miyamoto

Safety and Effectiveness of a Novel Laser-Based Intravascular Lithotripsy System for Coronary Calcium: FRACTURE Study

JACC Cardiovasc Interv. 2026 Oct 26;19(20):2710-2722. doi: 10.1016/j.jcin.2026.08.018.ABSTRACTBACKGROUND: Intravascular lithotripsy (IVL) has emerged as a promising option to modify calcium.OBJECTIVES: This study evaluated the safety and effectiveness of a novel laser- and optic-based quad-emitter I

M Margaret McEntegart

Calcium Fracture Detection by Optical Coherence Tomography Versus Intravascular Ultrasound Following Intravascular Lithotripsy

JACC Cardiovasc Interv. 2026 Oct 26;19(20):2694-2705. doi: 10.1016/j.jcin.2026.07.053.ABSTRACTBACKGROUND: Calcium fracture is a metric used to assess lesion preparation success. We have shown previously that optical coherence tomography (OCT) misses approximately half of these fractures. Intravascul

T Takamasa Tanaka

Uncracking the Relationship Between Intravascular Lithotripsy Pulses and Calcium Morphology

No abstractJACC Cardiovasc Interv. 2026 Oct 26;19(20):2691-2693. doi: 10.1016/j.jcin.2026.09.009.NO ABSTRACTPMID:42933910 | DOI:10.1016/j.jcin.2026.09.009

S Salvatore Brugaletta

Morphology-Dependent Dose-Response of Intravascular Lithotripsy on Coronary Calcium Fracture

JACC Cardiovasc Interv. 2026 Oct 26;19(20):2679-2690. doi: 10.1016/j.jcin.2026.07.027.ABSTRACTBACKGROUND: Intravascular lithotripsy (IVL) uses ultrasonic acoustic pressure waves to modify calcification to enable optimal balloon and stent expansion in calcified lesions. However, the dose-response rel

S Sandeep Basavarajaiah

One-shot learning of paired association navigation with biologically plausible schemas

J Neurosci. 2026 Oct 26:e1803242026. doi: 10.1523/JNEUROSCI.1803-24.2026. Online ahead of print.ABSTRACTAfter learning a multiple paired-association (MPA) navigation task, rodents can rapidly learn new cue-location associations after a single exposure, a phenomenon proposed to be facilitated by cogn

M M Ganesh Kumar

Loss of precordial T-wave balance preceding evolution into Wellens syndrome

No abstractBMJ Case Rep. 2026 Oct 26;19(10):e275066. doi: 10.1136/bcr-2026-275066.NO ABSTRACTPMID:42933852 | DOI:10.1136/bcr-2026-275066

K Kian Seng Ng

Prognostic value of the C-reactive protein-triglyceride-glucose index (CTI) for major adverse cardiovascular events in patients with coronary artery disease: a retrospective cohort study

No abstractBMJ Open. 2026 Oct 26;16(10):e119720. doi: 10.1136/bmjopen-2026-119720.NO ABSTRACTPMID:42933839 | DOI:10.1136/bmjopen-2026-119720

L Lirong Zhou

Exploring the nature, development and effects of complex emotions in Sheffield and Plymouth, UK: a longitudinal mixed methods study protocol

No abstractBMJ Open. 2026 Oct 26;16(10):e117088. doi: 10.1136/bmjopen-2026-117088.NO ABSTRACTPMID:42933832 | DOI:10.1136/bmjopen-2026-117088

S Sally Ohlsen

Acute exacerbation of chronic chest pain in a middle-aged man

No abstractHeart. 2026 Oct 26;112(22):1281-1282. doi: 10.1136/heartjnl-2026-328693.NO ABSTRACTPMID:42933802 | DOI:10.1136/heartjnl-2026-328693

X Xiaoting Li

Mechanical Aortic Valve Replacement in Congenital Heart Disease Using the SJM Valve

Thorac Cardiovasc Surg. 2026 Jan;74(S 03):e23-e30. doi: 10.1055/a-2960-9423. Epub 2026 Oct 26.ABSTRACTBACKGROUND: Mechanical aortic valve replacement (mAVR) with the St. Jude Medical (SJM) prosthesis is an established treatment. However, data on prosthesis-related adverse events in patients with con

T Theresa Holst

Analysis of the dynamic evolution and immunosuppressive functions of myeloid cells in gliomas based on single-cell transcriptomics

Brain Res. 2026 Oct 26:150604. doi: 10.1016/j.brainres.2026.150604. Online ahead of print.ABSTRACTBACKGROUND: Glioblastoma (GBM) is the most common and lethal primary brain tumor. However, the dynamic evolution of myeloid cells within its microenvironment and their role in immune suppression remain

H Hao Yuan

Nanoparticles for cardiovascular diseases: identifying and overcoming barriers in translating preclinical success to clinical applications

Adv Drug Deliv Rev. 2026 Oct 26:115980. doi: 10.1016/j.addr.2026.115980. Online ahead of print.ABSTRACTNanoparticles (NPs) have emerged as versatile platforms for drug delivery in cardiovascular diseases (CVDs), demonstrating robust efficacy in preclinical models by stabilizing atherosclerotic plaqu

A Ali Ahmadi

The implications of Amyloid Burden on Cardiac Structure and Prognosis

No abstractJ Nucl Cardiol. 2026 Oct 26:103004. doi: 10.1016/j.nuclcard.2026.103004. Online ahead of print.NO ABSTRACTPMID:42933593 | DOI:10.1016/j.nuclcard.2026.103004

Y Yoav Hammer